- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT03313388
Tart Cherry Juice for Exercise Performance and Recovery
The Effect of Tart Cherry Juice on Fat Metabolism, Exercise Performance, and Recovery
Tutkimuksen yleiskatsaus
Yksityiskohtainen kuvaus
Tart cherries are rich in bioactive components (i.e. flavonoids) that have anti-inflammatory and anti-oxidant properties. Inflammation and lipid peroxidation causes damage of skeletal muscle membranes during intense exercise. The damage of muscle increases the amount of time for muscle to recover from intense exercise, and can cause muscle strength to be reduced for days. When tart cherries in a concentrated form (i.e. as juice or powder) are consumed in the days leading up to intense exercise, there is a protective effect against inflammation, and lipid peroxidation . This theoretically prevents damage to the lipid component of muscle fibre membranes and helps to preserve muscle function - when muscle is damaged by intense exercise (i.e. either repetitive aerobic activity or high-force muscle contraction), consumption of cherry juice enhances the rate of muscle strength recovery following exercise compared to when a placebo (i.e. non-cherry) beverage is consumed . Muscle damage may be protected by cherry juice consumption; however, all studies evaluating the protective effect of cherries have assessed muscle damage by measuring muscle proteins in the blood. This rather indirect measure of muscle damage is highly variable and not always an accurate assessment of muscle damage; this may be why some studies indicate a reduction in markers of muscle damage with cherry juice consumption while others do not.
A more direct assessment of muscle damage can be obtained by applying electrical stimulation at different frequencies to a muscle before and after intense exercise and assessing the reduction in force output in response to low-frequency and high-frequency stimulation. After intense exercise, the force output at low frequencies of stimulation is often reduced, while the force output at high frequencies is maintained; a phenomenon termed "low frequency fatigue". When muscle is stimulated to contract (either voluntarily by the nervous system or involuntarily through electrical stimulation) calcium is released inside muscle. This calcium release leads to muscle contraction. When muscle undergoes intense exercise, there is damage to muscle membranes, including membranes inside muscle that are responsible for calcium release. This causes a lower amount of calcium to be released with each muscle contraction. Normally, if high frequencies of electrical stimulation are applied to muscle, a very large amount of calcium is released inside muscle - an amount which is "more than enough" to cause a high amount of muscle contraction and high force output. If muscle fibre membranes responsible for release of calcium are damaged, a lower amount of calcium is released, but because "more than enough" calcium is usually released with high frequency stimulation, the lower amount of calcium released with muscle damage is still enough to cause high force of muscle contraction. The force response to low frequencies of stimulation; however, is dramatically reduced when muscle is damaged - usually only a small amount of calcium is released when low frequencies of stimulation are delivered to muscle. Following muscle damage, the smaller amount of calcium released causes lower force production at low stimulation frequency. Low force production at low stimulation frequencies, with a relatively maintained force production at high stimulation frequencies therefore indicates that muscle damage has occurred. This lower muscle force capability at low frequencies of stimulation has dramatic effects on endurance performance because typical endurance performance relies on repeated low-force muscle contractions, as opposed to the few high-force contractions that might be required in other sports (i.e. short sprinting events or field events such as shot put).
The study we are proposing will use this measurement (i.e. ratio of low frequency force to high frequency force output) as a more direct measure of muscle damage. We predict that if cherry juice is consumed in the days leading up to a bout of muscle-damaging endurance exercise, muscle damage will be lower (as indicated by a faster recovery of low-frequency fatigue following the bout of exercise) than when a comparison-drink (i.e. Gatorade) is consumed.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Kanada, S7N 5B2
- College of Kinesiology, University of Saskatchewan
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- experienced cyclist (i.e. bicycle exercise at a vigorous intensity on a regular basis)
Exclusion Criteria:
- Allergies to cherries
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Muut
- Jako: Satunnaistettu
- Inventiomalli: Crossover-tehtävä
- Naamiointi: Kolminkertaistaa
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Tart Cherry Juice
290 mL per day of Tart Cherry juice for 7 days
|
Beverage to be consumed
|
|
Active Comparator: Gatorade
290 mL per day of Gatorade for 7 days
|
Beverage to be consumed
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Time time performance
Aikaikkuna: Day 5 of beverage consumption
|
Time to complete 10 km of cycling
|
Day 5 of beverage consumption
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Fat oxidation
Aikaikkuna: Day 5 of beverage consumption
|
Fat oxidation determined from gas analysis
|
Day 5 of beverage consumption
|
|
Carbohydrate oxidation
Aikaikkuna: Day 5 of beverage consumption
|
Carbohydrate oxidation determined from gas analysis
|
Day 5 of beverage consumption
|
|
Blood pressure
Aikaikkuna: Day 5 of beverage consumption
|
Blood pressure assessed by continuous blood pressure monitor
|
Day 5 of beverage consumption
|
|
Muscle pain
Aikaikkuna: Change from baseline to before, and immediately, 24 hours, and 48 hours after exercise
|
Muscle pain determined by a visual analog scale (participant marks a scale from 0 to 100 mm.
A score of 0 mm is "no pain".
A score of 100 mm is maximal pain).
|
Change from baseline to before, and immediately, 24 hours, and 48 hours after exercise
|
|
Quadriceps strength
Aikaikkuna: Change from baseline to before, and immediately, 24 hours, and 48 hours after exercise
|
Knee extensor strength determined by isometric contraction
|
Change from baseline to before, and immediately, 24 hours, and 48 hours after exercise
|
|
Low frequency fatigue
Aikaikkuna: Change from baseline to before, immediately, 24 hours, and 48 hours after exercise
|
Measured by force production at low and high stimulation frequencies as an index of muscle damage
|
Change from baseline to before, immediately, 24 hours, and 48 hours after exercise
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muut tutkimustunnusnumerot
- 16-273
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Drink
-
China Medical University HospitalRekrytointi
-
B. Braun Medical UK Ltd.ValmisSuun kautta otettava ravintolisäYhdistynyt kuningaskunta
-
Fresenius KabiValmisEnteraalinen ravitsemusSaksa
-
Chef V, LLCCitruslabsValmis
-
B. Braun Melsungen AGValmisAikuiset potilaat, jotka tarvitsevat runsaasti energiaa suun kautta otettavaa ravintolisääYhdistynyt kuningaskunta
-
Hospital General de MexicoFresenius KabiTuntematonAkuutti myelooinen leukemia, aikuisetMeksiko
-
Chung Shan Medical UniversityValmisMuut ihon ja ihonalaisen infektiotTaiwan
-
St Patrick's Hospital, IrelandTuntematon
-
Partnership to End AddictionFeinstein Institute for Medical ResearchAktiivinen, ei rekrytointiAlkoholin juominen | Alkoholismi | Alkoholiin liittyvät häiriöt | Alkoholin käytön häiriöt | Alkoholin väärinkäyttöYhdysvallat